Similar articles

• [Letter to the authors of the "Recommendations for clinical practice" concerning the prevention of renal osteodystrophy before extra-renal purification].

  Fournier A, Aparicio M. Fournier A, et al. Nephrologie. 1998;19(3):129-30. Nephrologie. 1998. PMID: 9633056 French. No abstract available.
• [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].

  Giachino G, Giacchino F, Jeantet A, Del Piano A, Garetto A, Pellerey M, Piccoli G. Giachino G, et al. Minerva Med. 1985 Mar 10;76(9-10):407-14. Minerva Med. 1985. PMID: 2984605 Italian. No abstract available.
• [Clinical evidence and treatment for optimum concentration of parathyroid hormone, calcium and phosphate in chronic renal failure].

  Hoshino J, Ubara Y, Takaichi K. Hoshino J, et al. Clin Calcium. 2004 May;14(5):731-7. Clin Calcium. 2004. PMID: 15577034 Review. Japanese.
• Prevention of renal osteodystrophy in predialysis patients.

  Sanchez CP, Goodman WG, Salusky IB. Sanchez CP, et al. Am J Med Sci. 1999 Jun;317(6):398-404. doi: 10.1097/00000441-199906000-00008. Am J Med Sci. 1999. PMID: 10372840 Review.
• Dialysis osteomalacia and aluminum toxicity: a form of renal osteodystrophy.

  Felsenfeld AJ. Felsenfeld AJ. ANNA J. 1985 Jun;12(3):189-91. ANNA J. 1985. PMID: 3848318 No abstract available.